Jason K Gurney1, Andrea A Florio2, Ariana Znaor3, Jacques Ferlay3, Mathieu Laversanne3, Diana Sarfati4, Freddie Bray3, Katherine A McGlynn2. 1. Cancer and Chronic Conditions Research Group, Department of Public Health, University of Otago, Wellington, New Zealand. Electronic address: jason.gurney@otago.ac.nz. 2. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. 3. Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. 4. Cancer and Chronic Conditions Research Group, Department of Public Health, University of Otago, Wellington, New Zealand.
Abstract
BACKGROUND: Incidence rates of testicular cancer (TC) have been increasing in many countries since, at least, the mid-20th century without clear explanation. Examining the varying trends across countries and time provides clues to understanding the causes of TC. OBJECTIVE: We have presented incidence data from 41 countries and evaluated incidence trends for the 35-yr period from 1978 to 2012. DESIGN, SETTING, AND PARTICIPANTS: Cancer registry data from Cancer Incidence in Five Continents (CI5) volumes V-XI, CI5plus, and the NORDCAN database were analysed. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Age-standardised rates of TC overall and by histological type were calculated. A joinpoint regression model of the natural log-transformed rates was used to calculate the average annual percent change (AAPC) in incidence. Age-period-cohort modelling was used to examine the effect of birth cohort on rates. RESULTS AND LIMITATIONS: While the highest incidence of TC remains in Northern Europe, the gap is closing between higher- and lower-incidence regions. Age-period-cohort modelling found flattening of risk among recent cohorts in Denmark and the UK, a steady increase in risk in the USA (particularly for seminomas), and an increase in risk among more recent cohorts in Costa Rica, Croatia, and Slovakia. CONCLUSIONS: The gap between low- and high-incidence countries is closing due to increases in the former and stabilisation in the latter. Understanding the causes of these and other differences in incidence rates between, and within, countries may help further our understanding of the aetiology of this cancer. PATIENT SUMMARY: We examined the rates of testicular cancer in different countries over time. These rates have been increasing, although the rates in high-incidence countries seem to be slowing down, while rates in low-incidence countries are catching up. These trends might help us understand what is causing testicular cancer in general.
BACKGROUND: Incidence rates of testicular cancer (TC) have been increasing in many countries since, at least, the mid-20th century without clear explanation. Examining the varying trends across countries and time provides clues to understanding the causes of TC. OBJECTIVE: We have presented incidence data from 41 countries and evaluated incidence trends for the 35-yr period from 1978 to 2012. DESIGN, SETTING, AND PARTICIPANTS: Cancer registry data from Cancer Incidence in Five Continents (CI5) volumes V-XI, CI5plus, and the NORDCAN database were analysed. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Age-standardised rates of TC overall and by histological type were calculated. A joinpoint regression model of the natural log-transformed rates was used to calculate the average annual percent change (AAPC) in incidence. Age-period-cohort modelling was used to examine the effect of birth cohort on rates. RESULTS AND LIMITATIONS: While the highest incidence of TC remains in Northern Europe, the gap is closing between higher- and lower-incidence regions. Age-period-cohort modelling found flattening of risk among recent cohorts in Denmark and the UK, a steady increase in risk in the USA (particularly for seminomas), and an increase in risk among more recent cohorts in Costa Rica, Croatia, and Slovakia. CONCLUSIONS: The gap between low- and high-incidence countries is closing due to increases in the former and stabilisation in the latter. Understanding the causes of these and other differences in incidence rates between, and within, countries may help further our understanding of the aetiology of this cancer. PATIENT SUMMARY: We examined the rates of testicular cancer in different countries over time. These rates have been increasing, although the rates in high-incidence countries seem to be slowing down, while rates in low-incidence countries are catching up. These trends might help us understand what is causing testicular cancer in general.
Authors: Freddie Bray; Lorenzo Richiardi; Anders Ekbom; Eero Pukkala; Martina Cuninkova; Henrik Møller Journal: Int J Cancer Date: 2006-06-15 Impact factor: 7.396
Authors: Christopher Kim; Katherine A McGlynn; Ruth McCorkle; Yonghong Li; Ralph L Erickson; Shuangge Ma; David W Niebuhr; Guangsheng Zhang; Yaqun Zhang; Yana Bai; Li Dai; Barry I Graubard; Tongzhang Zheng; Briseis Aschebrook-Kilfoy; Kathryn H Barry; Yawei Zhang Journal: J Psychosom Res Date: 2012-04-21 Impact factor: 3.006
Authors: Freddie Bray; Lorenzo Richiardi; Anders Ekbom; David Forman; Eero Pukkala; Martina Cuninkova; Henrik Møller Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-04 Impact factor: 4.254
Authors: Robert J Hamilton; Christina Canil; Noa Shani Shrem; Kopika Kuhathaas; Maria Di Jiang; Peter Chung; Scott North; Piotr Czaykowski; Sebastien Hotte; Eric Winquist; Christian Kollmannsberger; Armen Aprikian; Denis Soulières; Scott Tyldesley; Alan I So; Nicholas Power; Ricardo A Rendon; Martin O'Malley; Lori Wood; Michael A S Jewett Journal: Can Urol Assoc J Date: 2022-06 Impact factor: 2.052
Authors: Chiara Grasso; Maja Popovic; Elena Isaevska; Fulvio Lazzarato; Valentina Fiano; Daniela Zugna; John Pluta; Benita Weathers; Kurt D'Andrea; Kristian Almstrup; Lynn Anson-Cartwright; D Timothy Bishop; Stephen J Chanock; Chu Chen; Victoria K Cortessis; Marlene D Dalgaard; Siamak Daneshmand; Alberto Ferlin; Carlo Foresta; Megan N Frone; Marija Gamulin; Jourik A Gietema; Mark H Greene; Tom Grotmol; Robert J Hamilton; Trine B Haugen; Russ Hauser; Robert Karlsson; Lambertus A Kiemeney; Davor Lessel; Patrizia Lista; Ragnhild A Lothe; Chey Loveday; Coby Meijer; Kevin T Nead; Jérémie Nsengimana; Rolf I Skotheim; Clare Turnbull; David J Vaughn; Fredrik Wiklund; Tongzhang Zheng; Andrea Zitella; Stephen M Schwartz; Katherine A McGlynn; Peter A Kanetsky; Katherine L Nathanson; Lorenzo Richiardi Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-09-02 Impact factor: 4.090
Authors: Christine Hjorth Andreassen; Mette Lorenzen; John E Nielsen; Sam Kafai Yahyavi; Birgitte Grønkær Toft; Lars R Ingerslev; Christoffer Clemmensen; Lene Juel Rasmussen; Carsten Bokemeyer; Anders Juul; Anne Jørgensen; Martin Blomberg Jensen Journal: Br J Cancer Date: 2022-04-13 Impact factor: 9.075